Roots targets the high growth organic plant-based ‘meat’ market
Consumers are quickly waking up to the fact that consuming meat — especially highly processed meat — can have negative health outcomes and is contributing to the destruction of the environment.
Recognising both the health and environmental upsides of eating plant-based meat alternatives is translating to commercial success for businesses savvy enough to capitalise on this early trend.
With a market cap of almost US$7 billion, none have been more successful than Beyond Meat (NASDAQ: BYND).
Beyond Meat’s burgers and other plant-based products appeal not only to vegetarians, vegans, and the environmentally conscious, but they have now received official kosher certification. In a major coup, last month the company was selected by McDonald’s to supply the patties for burger its burger chains. The burgers will be known as P.L.T. burgers.
Also capitalising on the trend is the Bill Gates backed Impossible Foods, which just raised US$700 million from US venture capital firms to further its plant-based meat offerings.
Impossible Foods’ sells its burgers in US supermarkets and supply a number of major fast food outlets, including the country’s second largest fast food company, Burger King.
Its plant-based Impossible Burger “bleeds” like the real thing. Yet, it’s made from soy and potato proteins and its signature ingredient — the iron-rich compound, heme. Heme is produced when soy leghemoglobin is cooked and gives the veggie burger a meat-like flavour and its bleeding look.
However, plant-based meats may not be as healthy or environmentally friendly as it seems.
The industry relies heavily on industrially grown, high protein crops including soy, pea and potatoes, which require heavy use of herbicides and pesticides. This is the case for producers Beyond Meat and Impossible Foods and is one of the major criticisms they face.
For that reason, there’s growing demand for organically grown and environmentally conscious options for consumers.
Roots Sustainable Agricultural Technologies Ltd (ASX:ROO) addresses critical problems being faced by agriculture, including plant climate management and the shortage of water for irrigation.
Importantly, its technologies can assist in growing high-end organic meat replacement crops.
Roots has expanded into the plant-based meat market, initiating a planting program to examine the effects of its Root Zone Temperature Optimization (RZTO) and Irrigation by Condensation (IBC) technologies on several protein-laden crops to increase the content of leghemoglobin.
Its technologies work to increase a crop's leghemoglobin – also known as “heme” — a form of haemoglobin in plants and the key ingredient in what makes plant-based meats so tasty.
Stabilising plants’ root temperatures stimulates their immune systems, reducing susceptibility to pathogens and increasing the total biomass, and therefore potentially increasing total protein content.
Off the back of this discovery, ROO intend to lead the organic segment of the artificial meat replacement industry.
Roots is examining crops with a high protein content, either in the roots or in the canopy, which can be grown year-round using its RZTO technology. High end protein laden crops can be grown indoors where organic methods and cater for a lucrative organic meat replacement niche.
Roots will formally test the concept on high protein crops already planted at the company’s farm in Bet Halevi, Israel. Two high protein crops were planted in September 2019 using three configurations of the RZTO technology — horizontal, “Stub T-shape”, and a control group.
The final RZTO results from the first stage of the program are expected in November. Success here could lead to the planting of smaller size fields and greenhouses, thereby creating cost efficiencies and increasing profits for farmers using the RZTO system.
Roots’ planting program and potential technological breakthrough has already generated interest.
Discussions are underway with a European consultancy group and a bio-based company on a potential common application for a bi-national grant between Israel and Holland. The application will involve three companies, two of which must be European based.
The company is also assessing other potential opportunities to leverage its technology in the artificial meats space.
Roots CEO, Dr Sharon Devir said, “Increasing consumer concerns about the environmental and health impacts of meat coupled with a changing approach from the food industry to create meat alternatives has contributed to the large growth in the meat-replacement market.
“Our technology enables year-round production with relative low energy demand, decreasing the environmental impact. The organic meat replacement segment is emerging as a significant opportunity for Roots’ root zone heating and cooling technology and we see benefits for high-value crops grown indoors organically.”
Roots secures funding in placement
On Wednesday Roots announced that it had completed a $820,000 capital raising to sophisticated and professional investors.
The placement will see Roots issue 19,069,767 CDIs at A$0.043 each — a 15% discount to the 30-day volume weighted average price (VWAP) to 18 October 2019.
This comes after the company’s $1.66 million equity raising in May, which, after significant delays in seeking shareholder approval, resulted in a shortfall. This week’s equity raising is a result of that shortfall as well as ongoing needs.
This is a strong endorsement of Roots opportunities to commercialise its RZTO growth and will assist in expanding its marketing to cannabis growers and sales activity in the US.
Commenting on the placement Devir said, “We would like to welcome our new investors onto our register and recognise the continued support of our existing investors who participated.
“The placement is a strong endorsement of our substantial opportunities to commercialise our RZTO technology across multiple geographies, as we build on the momentum gained from initial sales. The funding secured in this placement will allow us to accelerate our growth in the US cannabis market, over the medium term.”
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.